TRAVERE THERAPEUTICS, INC.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||
| Net Income | $-59.7M | $-47.9M | $117.2M | $-110.9M | $-34.6M | $-30.3M | $-23.0K |
| Depreciation & Amortization | $17.8M | $16.1M | $13.4M | $5.4M | $216.0K | $124.9K | — |
| Depreciation | $500.0K | $100.0K | $100.0K | — | — | — | — |
| Amortization | $17.3M | $16.0M | $13.2M | $5.3M | $324.0K | — | — |
| Stock-Based Compensation | $26.9M | $29.1M | $25.9M | $15.9M | $5.4M | $22.4M | — |
| Net Cash from Operating Activities | $7.4M | $-3.4M | $-1.4M | $-45.9M | $-17.6M | $-2.7M | $-689 |
| Investing Activities | |||||||
| Capital Expenditures | $887.0K | $1.4M | $22.0K | $663.0K | $117.0K | $24.8K | — |
| Business Acquisitions | $0 | $615.0K | $33.4M | $29.2M | $0 | — | — |
| Net Cash from Investing Activities | $45.6M | $10.4M | $-80.6M | — | $-5.4M | $-1.7M | — |
| Financing Activities | |||||||
| Dividends Paid | — | — | — | — | — | — | — |
| Stock Repurchases | — | $0 | $0 | $2.3M | $958.0K | — | — |
| Net Cash from Financing Activities | $5.4M | $-3.8M | $101.6M | $95.3M | $29.0M | $4.4M | — |
| Net Change in Cash | $58.4M | $3.2M | $19.6M | $12.2M | $6.0M | $1.3K | — |
| Free Cash Flow | $6.5M | $-4.9M | $-1.4M | $-46.5M | $-17.7M | $-2.8M | — |